Purpose: This paper introduces a method that maximizes the probability of satisfying the clinical goals in intensity-modulated radiation therapy treatments subject to setup uncertainty. Methods: The authors perform robust optimization in which the clinical goals are constrained to be satisfied whenever the setup error falls within an uncertainty set. The shape of the uncertainty set is included as a variable in the optimization. The goal of the optimization is to modify the shape of the uncertainty set in order to maximize the probability that the setup error will fall within the modified set. Because the constraints enforce the clinical goals to be satisfied under all setup errors within the uncertainty set, this is equivalent to maximizing the probability of satisfying the clinical goals. This type of robust optimization is studied with respect to photon and proton therapy applied to a prostate case and compared to robust optimization using an a priori defined uncertainty set. Results: Slight reductions of the uncertainty sets resulted in plans that satisfied a larger number of clinical goals than optimization with respect to a priori defined uncertainty sets, both within the reduced uncertainty sets and within the a priori, nonreduced, uncertainty sets. For the prostate case, the plans taking reduced uncertainty sets into account satisfied 1.4 (photons) and 1.5 (protons) times as many clinical goals over the scenarios as the method taking a priori uncertainty sets into account. Conclusions: Reducing the uncertainty sets enabled the optimization to find better solutions with respect to the errors within the reduced as well as the nonreduced uncertainty sets and thereby achieve higher probability of satisfying the clinical goals. This shows that asking for a little less in the optimization sometimes leads to better overall plan quality. C 2015 American Association of Physicists in Medicine. [http://dx
INTRODUCTION
Misalignment of the patient relative to the beams can lead to large differences between the planned and the delivered dose distributions in external beam radiation therapy. The conventional approach to take such errors into account is to apply margins during treatment planning. Planning is then performed to yield high dose to an enlarged target volume, called the planning target volume (PTV), and low doses to enlarged organ at risk (OAR) volumes.
For cases of heterogeneous density, and especially cases subject to ion treatment, conventional margins do not always provide the intended robustness against uncertainties. 1 Methods that explicitly compute dose distributions under a number of scenarios (e.g., patient setup shifts) and optimize all scenario doses simultaneously appear to lead to more robust plans in general. [2] [3] [4] [5] Many of the methods intended to create robust plans are based on robust optimization and aim to minimize the objective function value under the worst scenario. If the plan quality under the worst scenario is unacceptable, the optimization algorithm has no incentive to make the quality under other scenarios acceptable, which can lead to unnecessarily poor plan quality under these scenarios. 6 This calls for a method that determines which scenarios to consider in the robust optimization in order to achieve acceptable plan quality under as many scenarios as possible. In the present paper, we devise such a method.
The goal of the method that we propose is to maximize the probability that the setup error will fall within an uncertainty set, subject to the constraint that the clinical goals are satisfied for all setup errors within this set. Because it cannot be known a priori whether it is possible to satisfy the clinical goals within a given uncertainty set, the method includes the shape of the uncertainty set as a variable in the optimization. The optimization thus simultaneously determines the treatment plan and the set of errors against which the treatment plan should be robust.
The rationale for modifying the size of the uncertainty set is the same as the rationale for modifying margins. Margins are generally specified in accordance with the magnitudes of measured errors in order to ensure a high probability of meeting the planning goals. 7 However, in cases for which the conflicting goals between PTV coverage and OAR sparing cannot be simultaneously fulfilled, the margins are sometimes retracted in the directions that correspond to the problematic conflicts. 8 Hence, prostate tumors are often given less margin toward the rectum than in the other directions, not because the prostate is less likely to move posteriorly, but because rectum sparing is considered more important than robustness against such errors. A plan with such a margin is not robust against the target moving posteriorly but on the other hand satisfies the clinical goal of rectum sparing.
Changing the magnitudes of the errors against which the plan should be robust has similarities to some previous methods: Gordon and Siebers 9 iteratively updated the sizes of the PTVs and reoptimized the treatment plans until a specified probability of target coverage was met. Gordon et al. considered multiple setup error scenarios and tried to meet the clinical goals for a specified fraction of these. Bohoslavsky et al.
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optimized the expected value of the objective conditioned on that one of the P best outcomes will occur. Rather than trying to reach a predetermined probability or optimizing for a specific quantile, our method optimizes the probability of satisfying the clinical goals directly. It can thereby reach the highest probability for which the goals can be fulfilled. The methods of Yang et al. 13 and Sobotta et al.
14 consider a number of predetermined error scenarios and optimize over these to maximize the probability of satisfying the clinical goals. The method proposed in the present paper differs from these methods in that it does not use predetermined error scenarios. Instead, it considers uncertainty sets of errors, the dimensions of which can be modified. This makes it feasible to consider a smaller number of error scenarios, which reduces the planning time. Moreover, the ability to continuously modify the dimensions of the uncertainty sets enables higher precision than when the set of considered scenarios is predetermined.
To demonstrate the method that we introduce, we use it to perform retrospective planning on a prostate case using both photon-mediated intensity-modulated radiation therapy (IMRT) and intensity-modulated proton therapy (IMPT). The resulting plans are compared to plans optimized to be robust against all errors within a priori selected uncertainty sets.
PRELIMINARIES
Before formulating the problem in which the shape of the considered uncertainty set is optimized, we give a standard robust optimization formulation that aims to robustly satisfy the clinical goals of a radiation therapy treatment without modifying the uncertainty set. We also describe how the probability of satisfying the clinical goals can be computed on the basis of an uncertainty set.
2.A. Robust optimization with respect to clinical goals
Robust optimization with respect to clinical goals can be formulated as an optimization problem with constraints enforcing the clinical goals of all region of interests (ROIs) to be satisfied whenever the setup error falls within a given uncertainty set.
To formulate the robust optimization problem mathematically, we denote by d(x;s) the dose distribution as a function of the variables x (machine parameters or spot weights) and the setup shift s ∈ R
3
. For each ROI r from the set R enumerating the ROIs, we assume that the function f r of dose evaluates to 0 or less whenever the clinical goals of ROI r are satisfied. The uncertainty set is the set of setup errors under which the clinical goals should be satisfied. It is denoted by U and is a subset of
. This enables us to formulate the optimization problem for robustly satisfying the clinical goals as
where the objective g is selected to reflect some goal that is secondary to the clinical goals, such as minimizing the dose outside the target, and X is the set of feasible variables.
2.B. Probability of satisfying the clinical goals
A solution to problem (2.1) satisfies the clinical goals if the setup error falls within the uncertainty set U. The probability that the clinical goals are satisfied is therefore given by the probability that the setup error falls within U. Here, we specify how this probability can be calculated.
We consider radiation therapy treatment subject to systematic setup uncertainty. The coordinate system is defined such that the patient is fixed and that the beam isocenters move as a result of the setup error. The setup error is a random variable vector S that takes on values s in R 3 according to some assumed probability distribution. The value s determines the shift of the beam isocenters.
A solution to problem (2.1) ensures that whenever the setup error S takes on a value s that lies in the uncertainty set U, then f r (d(x;s)) will evaluate to 0 or less, implying that the clinical goals of ROI r are satisfied. The probability that the clinical goals will be satisfied is thus given by P(the clinical goals of all ROIs are satisfied)
where P(A) denotes the probability of the event A occurring and pdf(s) is the probability density function of the random variable S.
METHOD
When there is no treatment plan such that the clinical goals are satisfied under all setup errors within U, formulation (2.1) often yields unacceptable plans. Here, we present a method that avoids this problem by modifying the size of the uncertainty set U until a plan that satisfies the clinical goals under all setup errors within the modified uncertainty set can be found.
The set U is modified with the goal of maximizing probability equation (2.2).
We begin by introducing an idealized method for optimizing the uncertainty set. A computationally tractable approximation of the idealized method is given in Appendix A.
3.A. Uncertainty set optimization
To enable optimization of the uncertainty set, we introduce a parameterization of U: For each ROI r in R, we consider an individual uncertainty set U(α r ), in which the goals of ROI r should be satisfied. The set U(α r ) is a function of the non-negative vector α r , each component of which specifies the size of U(α r ) in a positive or negative axis direction. Because we consider errors in 3D, α r is an element of R 6 + . In nonaxis directions, U(α r ) is interpolated, see Appendix B for a mathematical definition. Figure 1 shows a 2D illustration of an uncertainty set U(α r ). The set U, in which the clinical goals of all ROIs are satisfied, is then given by U = ∩ r ∈R U(α r ).
Our goal is to find plans that maximize the probability of satisfying the clinical goals, which is the same as maximizing Eq. (2.2). We include the parameters α r for all ROIs as variables in the optimization and combine objective equation (2.2) with the constraints of Eq. (2.1) to achieve an idealized uncertainty set optimization problem according to
The objective function measures the probability that the setup error S falls within U = ∩ r ∈R U(α r ) and the constraints ensure that for each ROI r, the clinical goals of the ROI are satisfied when the setup error falls within the region U(α r ). Thus, the F. 1. 2D illustration of the uncertainty set U(α). The clinical goals are enforced whenever the setup error S falls within U(α). The non-negative scalar α i determines the size of the uncertainty set U (α) in the axis unit direction p i for i = 1, . . ., 4. In other directions, U (α) interpolates elliptically between these points. The scalarᾱ i corresponds to the a priori value of α i .
clinical goals of all ROIs are satisfied when the setup error falls within U. Note that g from Eq. (2.1) is not considered in Eq. (3.1). Once Eq. (3.1) is solved, g can be considered in a second optimization with α fixed. Problem (3.1) can be seen as roughly maximizing α r,i for all r in R and i = 1,...,6. However, while the constraints for all s in U(α r ) in Eq. (3.1) do not take the probability of the different scenarios into account, the objective function does. Hence, because large setup errors are generally less probable than small ones, it will be worth more in terms of improved objective value to increase α r,i when it is close to zero than when it is large. This means that it is worth more to extend U(α r ) so that it includes regions close to the origin than regions distant from the origin.
In order to achieve a computationally tractable problem, we discretize Eq. (3.1) . Specifically, the uncertainty set U(α r ) is discretized into a set of scenarios α r,i p i for i = 1,...,6, where p i are the positive and negative axes unit directions. The discretization is further explicated in Appendix A.
3.B. Computational study

3.B.1. Patient cases
Practical uncertainty set optimization according to Eq. (A1) was applied to a prostate case. A five-field IMRT treatment with equispaced beams beginning at 0
• and a two-field IMPT treatment with beams at 90
• and 270
• were optimized. The dose grid resolution was 2.5×2.5×2.5 mm 3 . The setup errors were assumed to follow a truncated normal distribution with standard deviation 0.5 cm, bounded to have length at most 1 cm. A transversal slice of the patient is shown in Fig. 2. 
3.B.2. Optimization
Uncertainty set optimization according to Eq. (A1) was implemented in a research version of the RayStation 2.8 treatment planning system (RaySearch Laboratories, Stockholm, Sweden). The optimization in RayStation is performed by a sequential quadratic programming algorithm. A similar method is described by Gill et al.
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The uncertainty set optimizations were started from plans optimized for seven iterations with fixed scenario positions. For IMRT, these iterations were F. 2. Transversal slice of the patient case. Contours indicate the target (white) and the rectum (gray).
fluence map optimization iterations. The resulting plans were converted to segments before the scenario positions were optimized in combination with direct step-and-shoot optimization. The optimization functions constituting the objectives and constraints used in the present paper are the standard quadratically penalizing functions defined mathematically by, e.g., Oelfke and Bortfeld. 16 When problem (A1) has been solved, α determines the largest errors that can be taken into account while the clinical goals are satisfied. When the uncertainty set optimization had determined α, we performed an additional optimization with α fixed to the determined value. The resulting plans were compared to plans optimized with α fixed to the a priori value corresponding to setup shifts of 1 cm from the nominal scenario. The optimization problem with fixed values of α is formulated as
where f r is the same as in Eq. (A1), N enumerates the ROIs for which the clinical goals are enforced in the nominal scenario only, O enumerates the OARs, and g r penalizes the mean dose of ROI r. This problem thus minimizes the mean dose to the OARs under the nominal scenario while requiring some clinical goals to be satisfied under all scenarios and other clinical goals to be satisfied under the nominal scenario.
3.B.3. Scenario dose calculation
During the optimizations, the scenario doses were calculated using the nominal mapping from fluence to dose, but with the fluence maps shifted (and bilinearly interpolated) according to the displacements of the scenarios.
In the robustness evaluation, the scenario doses were calculated with the patient positions shifted. The scenario dose calculation used during the optimization thus differed from that used in the evaluation. The discrepancy implies that constraints that are satisfied with respect to the doses used during optimization are not necessarily satisfied with respect to the evaluation doses.
Doses were computed by the dose calculation algorithms of RayStation. For IMRT, optimization was performed using RayStation's fast dose engine and followed by computation of final doses using its accurate dose engine. For IMPT, all doses were computed by its pencil beam algorithm. The line spacing and the energy layer separation (in water equivalent media) were both set to 5 mm, but to improve upon the approximate dose calculation with shifted fluences used during the optimization, auxiliary spots were computed for 2.5 mm line spacing, cf. Unkelbach et al.
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The weights of the auxiliary spots were not included as variables in the optimization.
RESULTS
We applied the uncertainty set optimization method to a prostate case. In our proof-of-concept, we considered simplified uncertainty sets consisting of error scenarios along one axis only. To actually maximize the probability of satisfying the clinical goals, additional directions and scenarios should typically be included, see Appendix A for more details. We began by solving Eq. (A1) to optimize the uncertainty set and then solved Eq. (3.2) using the optimized uncertainty set and the a priori uncertainty set.
The computations were performed under Windows 7 on a 64-bit desktop computer with 24 GB of RAM and an Intel Xeon W3580 processor with four 3.33 GHz cores. Running 200 iterations of robust optimization with respect to clinical goals on form (3.2) for the prostate case took 10 (photons) and 140 (protons) min, while the increased number of dose computations required for approximating the derivatives with respect to α by finite differences leads to optimization times of 20 (photons) and 230 (protons) min for 200 iterations of uncertainty set optimization according to Eq. (A1).
4.A. Uncertainty set optimization
The prostate case was simplified to only include setup shifts in the anterior and posterior directions. The clinical goals for the target and the rectum of the prostate case were assumed to require robustness. Other goals were included in the nominal scenario only. The optimization problem was formulated according to Eq. (A1), using the clinical goals presented in Table I as constraints. The discretization included, in addition to the nominal scenario, two scenarios each for the target and the rectum (anterior and posterior isocenter shifts), each of which was variable in the optimization.
The optimizations changed neither the posterior isocenter shift for the target nor the anterior isocenter shift for the rectum, but kept these at their initial (maximum) positions of 1 cm. Figure 3 constraints. Shortly after iteration 25, the isocenter shifts are being pushed outward, which improves the objective value. For IMRT, the uncertainty set optimization resulted in the positions 0.67 and 0.68 cm for, respectively, the target anterior and the rectum posterior isocenter shift scenarios. For IMPT, it resulted in the positions 0.72 and 0.74 cm.
4.B. Robust plans with optimized scenarios
The optimized scenario positions were used as fixed positions in standard robust optimizations according to formulation (3.2). This problem was solved also with the scenario positions fixed at the a priori locations (1 cm in the posterior and anterior directions). Since, with the a priori scenarios, the constraints could not be satisfied, the target and rectum goals were relaxed into a robust objective constituent max i=0, ..., 6  r ∈R f r (d(x;ᾱ r,i p i )) with weight 100 for that optimization. The resulting DVHs are shown in Fig. 4 . For both modalities, the plans with optimized scenarios neglect the 1 cm anterior isocenter shift for the target but in return achieve better target coverage under the other scenarios than the plans optimized with a priori scenarios.
For each of the methods using optimized and a priori uncertainty sets, each robust constraint of Table I (with volume level tolerance 0.5% and dose level tolerance 0.5 Gy) was evaluated under the optimized and the a priori scenarios. The number of satisfied robust constraints over these scenarios is shown in Table II .
DISCUSSION
Robust optimization aims for plans that are robust over all error scenarios within some uncertainty set. When the constraints cannot be satisfied under some scenarios, the plan quality under all scenarios within the set may suffer. After a slight reduction of the uncertainty set, it is sometimes possible to achieve better plan quality with respect to the scenarios within the smaller set. The results of this paper show that such reduction can moreover enable better plan quality with respect to the majority of the scenarios within the larger uncertainty set.
For the simplified goals of the prostate case, uncertainty set optimization resulted in the intuitively correct solution, which furthermore coincides with a known practice for reducing margins: 8 The posterior isocenter shift scenario for the target and the anterior isocenter shift scenario for the rectum did not move from their maximum positions, as could be expected because these scenarios were not in conflict with other scenarios. The other two scenarios moved to become compatible. By retracting these scenarios, the uncertainty set optimization enabled better solutions with respect to all other scenarios and thereby achieved higher probability of satisfying the clinical goals than optimization with the scenario positions fixed at the a priori locations. Asking for a little less in the optimization sometimes leads to better overall plan quality.
Uncertainty set optimization bears similarities to worst case scenario optimization 17 in the sense that constraints enforce fulfillment of the clinical goals under all considered scenarios. However, the objective to be maximized is the probability that the setup error falls within a variable uncertainty set. The optimization thus takes into account the probability distribution and the fact that the probability of errors diminishes with the magnitude of the errors. This is reminiscent of probabilistic planning concepts, 18, 5 in which the expected value of the objective function is optimized and the fact that the probability of errors diminishes with the size of the errors is directly reflected by that the objective contributions of such error scenarios are weighted by the small probabilities. A notable difference is that in probabilistic planning, all scenarios are considered in the objective, but weighted by the probability of the scenario occurring, whereas in uncertainty set optimization, scenarios not contained in the uncertainty set are neglected while the clinical goals are required to be fully satisfied for scenarios that are in the uncertainty set. A limitation of our approach is that we only take systematic setup errors into account. Random errors could be incorporated by dose or fluence blurring (see, e.g., Refs. 11 and 12), T II. The number of satisfied robust constraints for the prostate case under the three optimized scenarios and under the three a priori scenarios of each ROI. Five constraints and three scenarios make the maximum 15 for each group of scenarios.
No. of satisfied constraints in evaluation
Method
Optimized scenarios A priori scenarios Total IMRT with respect to optimized scenarios 14 11 25 IMRT with respect to a priori scenarios 9 9 18
IMPT with respect to optimized scenarios 15 12 27 IMPT with respect to a priori scenarios 9 9 18 but this requires the biological assumption that overdosing an OAR in one fraction can be compensated by a lower dose in another fraction, which we are inclined not to make.
CONCLUSION
A method was introduced that maximizes the probability of satisfying the clinical goals in the presence of setup uncertainty. The method was applied to a prostate case and the resulting plans were compared to plans optimized with respect to errors within a priori defined uncertainty sets. The plans of the proposed method fulfilled 1.4 (photons) and 1.5 (protons) times as many clinical goals over the scenarios as the method using a priori defined uncertainty sets.
APPENDIX A: PRACTICAL UNCERTAINTY SET OPTIMIZATION
Because U(α r ), as defined in Appendix B, contains infinitely many points (unless α r = 0), formulation (3.1) has
